endpts.com/pfizer-scoops-up-global-blood-therapeutics-and-its-sickle-cell-therapies-for-5-4b
Pfizer is dropping $5.4 billion to acquire Global Blood Therapeutics. Just ahead of the weekend, word got out that Pfizer was close to clinching a $5 billion buyout — albeit with other potential buyers still at the table. The pharma giant, flush with cash from Covid-19 vaccine sales, apparently got
Posted by
editors
Tap to Copy the Short Url to This Post:
bto.sh/44tf2k62 
One-Stop Business News backed by Mark Cuban. Free to Use →